Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy.

Literature DB >> 9670910

Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy.

Abstract

Entities: Disease Species

Mesh：

Substances：
Anticonvulsants

Year: 1998 PMID： 9670910 DOI： 10.1111/j.1528-1157.1998.tb01167.x

Source DB: PubMed Journal: Epilepsia ISSN： 0013-9580 Impact factor: 5.864

Keyword Cloud
Cited

× No keyword cloud information.

42 in total

Review 1. New antiepileptic drugs: comparative studies of efficacy and cognition.

Authors: Steven L Weinstein; Joan Conry
Journal: Curr Neurol Neurosci Rep Date: 2002-03 Impact factor: 5.081

2. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors: Sarah J Nevitt; Maria Sudell; Catrin Tudur Smith; Anthony G Marson
Journal: Cochrane Database Syst Rev Date: 2019-06-24

Review 3. Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review.

Authors: Sarah J Nevitt; Catrin Tudur Smith; Anthony G Marson
Journal: Cochrane Database Syst Rev Date: 2019-07-31

4. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

Authors: Tracy Glauser; Shlomo Shinnar; David Gloss; Brian Alldredge; Ravindra Arya; Jacquelyn Bainbridge; Mary Bare; Thomas Bleck; W Edwin Dodson; Lisa Garrity; Andy Jagoda; Daniel Lowenstein; John Pellock; James Riviello; Edward Sloan; David M Treiman
Journal: Epilepsy Curr Date: 2016 Jan-Feb Impact factor: 7.500

10. Comparative effectiveness of eight antiepileptic drugs in adults with focal refractory epilepsy: the influence of age, gender, and the sequence in which drugs were introduced onto the market.

Authors: Jussi Mäkinen; Jukka Peltola; Jani Raitanen; Tiina Alapirtti; Sirpa Rainesalo
Journal: J Neurol Date: 2017-05-31 Impact factor: 4.849

Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy.

Review 1. New antiepileptic drugs: comparative studies of efficacy and cognition.

2. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Review 3. Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review.

4. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

5. Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox-Gastaut Syndrome.

Review 6. The promise of futility trials in neurological diseases.

Review 7. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

Review 8. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Review 9. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.

10. Comparative effectiveness of eight antiepileptic drugs in adults with focal refractory epilepsy: the influence of age, gender, and the sequence in which drugs were introduced onto the market.